Martek Biosciences Corp. (Columbia, MD) is restructuring its Winchester, KY, facility to improve capacity and reduce manufacturing and operating costs.
Martek Biosciences Corp. (Columbia, MD) is restructuring its Winchester, KY, facility to improve capacity and reduce manufacturing and operating costs. The company will also reduce its workforce and transfer certain manufacturing and distribution processes to the company’s Kingstree, SC, site. The company says it is looking to offset price reductions stemming from the company’s current infant-formula contracts, such as with Mead Johnson.
Regarding Mead Johnson, Martek has extended its sole-supplier agreement with the company for docosahexaenoic acid (DHA) and arachidonic acid (ARA). Under the agreement, Martek will remain Mead Johnson’s sole supplier of DHA and ARA for all Mead Johnson infant-formula products through December 2015.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.